Currently, Ernexa Therapeutics Inc’s (ERNA) stock is trading at $1.93, marking a fall of -19.38%% from last night’s close. At this price, the stock is -95.09% below its 52-week high of $39.38 and -6.97% above its 52-week low of $2.08. Based on the past 30-day period, the stock price is -48.71% below the high and +7.31% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ERNA’s SMA-200 is $7.64.
As well, it is important to consider ERNA stock ratios such as price-to-sales, which is currently 26.37.
How does Ernexa Therapeutics Inc (ERNA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.
Ernexa Therapeutics Inc (NASDAQ: ERNA) Ownership Details
I will give a breakdown of the key shareholders in Ernexa Therapeutics Inc (ERNA). Recent figures show that the company’s insiders hold 61.04% of shares. A total of 28 institutional investors hold shares in the company, making 1.35% of its stock and 3.46% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Geode Capital Management, LLC holding total of 19.54 shares that make 0.27% of the company’s total number of shares and are currently priced at 36643.0.
The securities firm Corient Private Wealth LLC holds 17.52 shares of ERNA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.24% , and the holding percentage of shares is valued at 32857.0.
An overview of Ernexa Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Ernexa Therapeutics Inc (ERNA) traded 125,632 shares per day, with a moving average of $2.72 and price change of -1.54. With the moving average of $2.97 and a price change of -0.92, about 57,019 shares changed hands on average over the past 50 days. Finally, ERNA’s 100-day average volume is 40,399 shares, alongside a moving average of $3.52 and a price change of -4.57.
